CClinicalTrials.gg
CompletedNCT03690518QUALIREHABUpdated Jan 31, 2023

Rehabilitation of Adolescents and Young Adults With Congenital Heart Diseases

An interventional study of Cardiac rehabilitation in Heart Defects, Congenital, Adolescent and Young Adult, sponsored by University Hospital, Montpellier. Completed at 17 sites in France. Open to participants aged 13 Years to 25 Years. Per ClinicalTrials.gov, last updated 2023-01-31.

Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
142
Allocation
Randomized
Ages
13 Years to 25 Years
Sex
All
01

Study summary

The investigators aim to measure the impact of a rehabilitation program in congenital cardiology in terms of health related quality of life. The orginality of the rehabilitation program consists in its design : initial hospitalizationfor a short period of time (5 days) at the rehabilitation center, followed by 11 weeks of rehabilitation at home under the supervision of a specialized sports trainer.

Read the detailed description

Adolescents and adults with congenital heart disease (CHD) have reduced exercise capacity compared to the general population, even for "simple" heart disease.

Regular physical activity is known to reduce the risk of acquired heart disease.

Cardiac rehabilitation programs have been largely developed to manage adult coronary and heart failure patients, which is not yet the case routinely in patients, adults and children, carriers of DC.

The investigators assume that patients who participate in this program will improve their quality of life compared to controls.

The orginality of the rehabilitation program consists in its design : initial hospitalizationfor a short period of time (5 days) at the rehabilitation center, followed by 11 weeks of rehabilitation at home under the supervision of a specialized sports trainer .

02

Conditions studied

  • Heart Defects, Congenital
  • Adolescent
  • Young Adult

Keywords

  • cardiac rehabilitation
  • Congenital heart diseases
  • Heart defects, congenital
  • Adolescent
  • Young adult
  • Physical activity
  • Cardio-pulmonary exercice test
  • Oxygen uptake
  • Muscular deconditioning
  • Patient education as topic
  • Quality of life
  • Health Knowledge, Attitudes, Practice
03

In context

Heart Diseases

3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.

This study's enrollment of 142 is above the median of 100 across 1,778 interventional studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 224 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient aged 13 to 25 years included
  • With a congenital heart diseases (CHD) as defined in the international CHD classification.
  • Recent (\< 3 months) cardio-pulmonary exercise test (CPET)with maximum oxygen uptake (VO2max) \<80% of theoretical values and/or first ventilatory anaerovic threshold (VAT) \<55% of VO2max.
  • Consent of the adult patient or the parents or legal guardians of the minor patient.
  • Beneficiary of the social security scheme.

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled arrhythmia.
  • Cardiac surgery planned during the rehabilitation program.
  • Severe musculoskeletal disorders.
  • Severe intellectual disability that does not allow the quality of life questionnaire to be completed.
  • Pregnancy.
  • Patient who already underwent cardiac rehabilitation in the last 24 months.
  • All medical contraindications to perform a cardiorespiratory stress test.
  • Uncontrolled heart failure (NYHA IV)
  • Obesity (BMI > 30)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
142 participants (actual)

Study arms

  • No intervention
    Control

    Controls will have a regular follow-up without any intervention (no rehabilitation program)

  • Active comparator
    Rehabilitaiton

    Cardiac rehabilitation: Rehabilitation will have a regular follow-up with intervention (rehabilitation program)

    Other: Cardiac rehabilitation

Interventions

  • OtherCardiac rehabilitation

    Educational/Counseling/Training : Rehabilitation, , cardiovascular rehabilitation in congenital heart disease

06

What researchers measure

Primary outcomes

  1. Quality of life score (PedsQL, 24 items), range score from 0 to 100, higher score indicating better quality of life.

    Evolution of the PedsQL 4.0 self-reported scores from month 0 to month 12

    Time frame: follow up of patients over 12 months

Secondary outcomes

  1. Peak oxygen uptake (VO2max, ml/kg/min)

    Time frame: Month 0 and Month 12

  2. ventilatory anaerobic threshold (VAT, ml/kg/min)

    Time frame: Month 0 and Month 12

  3. knowledge of the disease

    Disease knowledge questionnaire (Leuven questionnaire, 34 items, total range score from 0 to 100, a higher score indicating better knowledge)

    Time frame: Month 0 and Month 12

  4. cardiac events

    number of consultation in cardiology, number of hospitalization in cardiology, number of cardiovascular events

    Time frame: Month 0 and Month 12

  5. physical activity scoring

    Score of physical activity (Ricci and Gagnon questionnaire, 9 items, total range score from 6 to 45, higher score indicating a higher level of physical activity)

    Time frame: Month 0 and Month 12

  6. functional NYHA class

    NYHA functional class= New York Association functional class from the World Health Organization

    Time frame: Month 0 and Month 12

  7. Cardiac output during exercise

    Variation of cardiac output during exercise tests measured by impedance measurement (Physioflow)

    Time frame: Month 0 and Month12

07

Study locations

17 sites
  • Haut Lévêques - Bordeaux University Hospital
    Bordeaux, 33000, France
  • Brest University Hospital
    Brest, France
  • Gabriel Montpied Hospital- Clermont Ferrand University Hospital
    Clermont-Ferrand, 63000, France
  • Grenoble Alpes University Hospital
    Grenoble, 38000, France
  • Marie Lannelongue Hospital
    Le Plessis-Robinson, 92350, France
  • Children and Mother Hospital - Limoges University Hospital
    Limoges, 87000, France
  • La Timone- Public Assistance - Marseille hospitals
    Marseille, 13000, France
  • Liberal Cabinet Massy
    Massy, 91300, France
  • Arnaud de Villeneuve - University Hospital
    Montpellier, 34 000, France
  • Nice University Hospital
    Nice, France
  • Caremeau - Nimes University Hospital
    Nîmes, 30000, France
  • Saint-Pierre Institute
    Palavas-les-Flots, 34250, France
  • Necker - Sick Children Hospital - Paris
    Paris, 75015, France
  • La Miletrie -Poitier University Hospital
    Poitiers, 86000, France
  • Children Hospital - Toulouse University Hospital
    Toulouse, 31000, France
  • Pasteur Clinic
    Toulouse, 31000, France
  • Barbois Hospital - Nancy University Hospital
    Vandœuvre-lès-Nancy, 54500, France
08

References and documents

Publications

  • Amedro P, Gavotto A, Legendre A, Lavastre K, Bredy C, De La Villeon G, Matecki S, Vandenberghe D, Ladeveze M, Bajolle F, Bosser G, Bouvaist H, Brosset P, Cohen L, Cohen S, Corone S, Dauphin C, Dulac Y, Hascoet S, Iriart X, Ladouceur M, Mace L, Neagu OA, Ovaert C, Picot MC, Poirette L, Sidney F, Soullier C, Thambo JB, Combes N, Bonnet D, Guillaumont S. Impact of a centre and home-based cardiac rehabilitation program on the quality of life of teenagers and young adults with congenital heart disease: The QUALI-REHAB study rationale, design and methods. Int J Cardiol. 2019 May 15;283:112-118. doi: 10.1016/j.ijcard.2018.12.050. Epub 2018 Dec 20. PubMed 30616811 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 31, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03690518
Lead sponsor
University Hospital, Montpellier
Responsible party
Sponsor
First posted
Oct 1, 2018
Start date
Jul 27, 2018
Primary completion
Sep 12, 2022
Completion
Sep 12, 2022
Last update
Jan 31, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion